Our study is the first to investigate the association between IL-17A mRNA and CRC prognosis based on the data of patients from all tumor stages (except for the GSE103479 and GSE75500 datasets that included only stage II and III patients, and GSE87211 that did not include tumor stage data). Here, IL17A is linked to colorectal carcinoma.